Literature DB >> 16267070

Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.

Ole Dyg Pedersen1, Steen Z Abildstrøm, Michael M Ottesen, Christian Rask-Madsen, Henning Bagger, Lars Køber, Christian Torp-Pedersen.   

Abstract

AIMS: Atrial fibrillation (AF) is a common complication in patients with acute myocardial infarction and is associated with an increase in the risk of death. The excess mortality associated with AF complicating acute myocardial infarction has not been studied in detail. Observations indicate that AF facilitates induction of ventricular arrhythmias, which may increase the risk of sudden cardiovascular death (SCD). A close examination of the mode of death could potentially provide useful knowledge to guide further investigations and treatments. METHODS AND
RESULTS: We analysed the relation between AF/atrial flutter (AFL) and modes of death in 5983 consecutive patients discharged alive after an acute myocardial infarction screened in the TRAndolapril Cardiac Evaluation registry. This cohort of patients with an enzyme-verified acute myocardial infarction was admitted to 27 centres in 1990-92. Survival status was obtained 2 years after screening of the last patient. An independent endpoint committee assessed the modes of death. Left ventricular ejection fraction was determined in all the screened patients and information about presence or absence of AF/AFL was prospectively collected. Sustained or paroxysmal AF/AFL was observed in 1149 patients (19%) during hospitalization. During follow-up, 1659 patients (34%) died: 482 (50%) patients with AF/AFL and 1177 (30%) patients without AF/AFL, P<0.001. SCD occurred in 536, non-SCD occurred in 725, and 398 died of non-cardiovascular causes (includes 142 unclassifiable cases). The adjusted risk ratio of AF/AFL for total mortality was 1.33 (95% CI: 1.19-1.49; P<0.0001) and the risk ratio for SCD was 1.31 (95% CI: 1.07-1.60; P<0.009). The adjusted risk ratio of AF/AFL for non-SCD was 1.43 (95% CI: 1.21-1.70; P<0.0001).
CONCLUSION: The excess mortality observed in patients with AF/AFL following acute myocardial infarction is due to a significant increase in both SCD and non-SCD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267070     DOI: 10.1093/eurheartj/ehi629

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  33 in total

1.  Electrocardiographic predictors of arrhythmic death -"what is the role of atrial fibrillation?".

Authors:  Hari Dandapantula; Laxman Chandu
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

2.  Point-of-care testing of cardiac autonomic function for risk assessment in patients with suspected acute coronary syndromes.

Authors:  C Eick; M Duckheim; P Groga-Bada; N Klumpp; S Mannes; C S Zuern; M Gawaz; K D Rizas; Axel Bauer
Journal:  Clin Res Cardiol       Date:  2017-03-22       Impact factor: 5.460

Review 3.  ICD programming to reduce shocks and improve outcomes.

Authors:  Valentina Kutyifa; Wojciech Zareba; Arthur J Moss
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

4.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

Review 5.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

Review 6.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

7.  An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

Authors:  Etienne Aliot; Günter Breithardt; Josep Brugada; John Camm; Gregory Y H Lip; Panos E Vardas; Markus Wagner
Journal:  Europace       Date:  2010-05       Impact factor: 5.214

8.  Effects of rosuvastatin on atrial nerve sprouting and electrical remodeling in rabbits with myocardial infarction.

Authors:  Xujuan Hou; Yujiao Zhang; Ximin Wang; Shaohua Zheng; Yinglong Hou; Mei Gao
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 9.  Update on the use of trandolapril in the management of cardiovascular disorders.

Authors:  Ariel Diaz; Anique Ducharme
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk).

Authors:  Axel Bauer; Petra Barthel; Raphael Schneider; Kurt Ulm; Alexander Müller; Anke Joeinig; Raphael Stich; Antti Kiviniemi; Katerina Hnatkova; Heikki Huikuri; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  Eur Heart J       Date:  2008-12-23       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.